Genoa Neuropsychiatric Pharmacy Learning Module: Substance Abuse
Activity Dates: 07/01/2011 - 07/01/2013
This course is closed. Please look for other available products in CPNP University.
If you are a pharmacist, nurse practitioner or other healthcare professional involved in the comprehensive medication management of psychiatric and/or neurological patients, we invite you to participate in this online course.
At the end of this program, the participant should be able to:
Identify signs and symptoms of acute intoxication, acute withdrawal, and chronic dependency associated with the use of the following drugs of abuse:
- Opiates (pain medications, heroin)
- Stimulants (Methamphetamines)
- Describe the pharmacologic properties and pharmacokinetic parameters for drug therapies used in the treatment of substance use disorders.
- Select appropriate pharmacotherapy (agent, dose, duration of therapy) for substance use disorders based on current practice guidelines.
- Develop a monitoring plan that includes assessment of efficacy, and evaluation for adverse effects, drug interactions, and toxicity given a patient undergoing treatment for a substance use disorder,
- Compose a management strategy given a specific drug-related problem in a patient with a substance use disorder.
- Develop a plan to provide appropriate patient education for substance use disorders
You will proceed through the following steps to satisfactorily complete this course:
- Review the full content of the activity and reflect upon its teachings.
- Complete the post-test at the end of the activity no later than the closing activity date. (login first)
- Complete the evaluation at the end of the activity. (login first)
- If necessary, complete the post-test retest no later than the closing activity date.
- Receive a passing grade (60%).
- Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor.
This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.
Participants in this course must complete an examination and achieve a score of 60% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.
- Internet Explorer 7+, Firefox 3+, Safari 3+, Chrome 13+
- Adobe Flash Player 10+
- Adobe Acrobat Reader 8+ or other PDF viewer
- 1024x768 resolution or greater
- 1GB RAM or more
- Any Operating System capable of the above requirements
Continuing Education Credit and Disclosures
Activity Dates: 07/01/2011 - 07/01/2013
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-11-052-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE and ACCME credit is accepted for certification renewal.
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.0 contact hours (0.10 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is # 0284-0000-11-052-H01-P (Knowledge) (1.0 contact hours).
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information and disclosures). The opinions expressed in the educational activity do not necessarily represent the views of CPNP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Recommend This Activity
|Suggest this activity to others:|